
Novartis will shell out $2.1 billion to acquire cancer drug developer Endocyte in a move to leverage the company’s technology …

Endocyte and partner MSD have released positive mid-stage trial results for their investigational lung cancer drug vintafolide. The treatment met …

David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …

Merck is to pay $120 million to US biopharma company Endocyte as part of a deal to develop and commercialise …
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact

